Worth reading
47Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
20000
SharesWording
Conditional
How definitive the wording is.Details of issuance or disposal
Issuance of the Fifth Series of Stock Options (Share Acquisition Rights)
Who receives how much
20,000 shares of the Company's common stock (200 share acquisition rights, 100 shares per right)
2 executive officers of the CompanyEquivalent to 20,000 shares (200 share acquisition rights)
The lower thin line represents the existing number of shares to which these shares will be added.
Terms of the stock acquisition rights
Exercise price
The initial exercise price has not been determined. It will be based on 1.05 times the average closing price during the month preceding the month in which the allotment date falls, with the closing price on the allotment date serving as the floor. Adjustment provisions apply in connection with stock splits, consolidations and other events.
Exercise period
Start Date 8 August 2028 / End date 7 August 2036
Number of Stock Acquisition Rights
Total number issued 200 (number scheduled for allotment) / Number of unexercised units Not disclosed
Reason for acquisition without consideration
If a proposal concerning a corporate reorganization or similar matter is approved at a shareholders meeting, if the holder of the share acquisition rights becomes unable to exercise them because the exercise conditions are no longer satisfied, or if the holder of the share acquisition rights dies.
Categories and Number of Persons Covered
2 executive officers of the Company, 200 share acquisition rights (equivalent to 20,000 shares)
Basis for determining the amount to be paid
The exercise price will be calculated by multiplying by 1.05 the average closing price of the Company's common stock on each trading day on the Tokyo Stock Exchange during the month preceding the month in which the allotment date falls. However, if this amount is lower than the closing price on the allotment date, the latter price will apply. The specific amount is scheduled to be determined on 24 August 2026.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of the Fifth Series of Stock Options (Share Acquisition Rights) |
| Number of shares to be issued or disposed of | 20,000 shares of the Company's common stock (200 share acquisition rights, 100 shares per right) |
| Intended allottee | Name 2 executive officers of the Company / Number of Shares Equivalent to 20,000 shares (200 share acquisition rights) |
| Basis for determining the amount to be paid | The exercise price will be calculated by multiplying by 1.05 the average closing price of the Company's common stock on each trading day on the Tokyo Stock Exchange during the month preceding the month in which the allotment date falls. However, if this amount is lower than the closing price on the allotment date, the latter price will apply. The specific amount is scheduled to be determined on 24 August 2026. |
| Exercise price | The initial exercise price has not been determined. It will be based on 1.05 times the average closing price during the month preceding the month in which the allotment date falls, with the closing price on the allotment date serving as the floor. Adjustment provisions apply in connection with stock splits, consolidations and other events. |
| Exercise period | Start Date 8 August 2028 / End date 7 August 2036 |
| Number of Stock Acquisition Rights | Total number issued 200 (number scheduled for allotment) / Number of unexercised units Not disclosed |
| Reason for acquisition without consideration | If a proposal concerning a corporate reorganization or similar matter is approved at a shareholders meeting, if the holder of the share acquisition rights becomes unable to exercise them because the exercise conditions are no longer satisfied, or if the holder of the share acquisition rights dies. |
| Categories and Number of Persons Covered | 2 executive officers of the Company, 200 share acquisition rights (equivalent to 20,000 shares) |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To further increase motivation and morale to improve business performance and achieve further enhancement of corporate value.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.